Alpha DNA Investment Management »

ACADIA Pharmaceuticals shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $517k 17k 31.31

More positions owned by Alpha DNA Investment Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Wells Fargo & Company (WFC)
Wal-Mart Stores (WMT)
Chevron Corporation (CVX)
EOG Resources (EOG)
Nextera Energy (NEE)
Cisco Systems (CSCO)
Chubb (CB)
Abbvie (ABBV)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Bank of America Corporation (BAC)

View all positions for Alpha DNA Investment Management

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
EcoR1 Capital
T. Rowe Price Associates
D. E. Shaw & Co
Fred Alger Management
Palo Alto Investors
Millennium Management
Emerald Advisers
Norges Bank Investment Management
Jupiter Asset Management
Voloridge Investment Management
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft

View all funds holding ACADIA Pharmaceuticals